Tag Archives: multi-modality

Adjuvant Radiotherapy for Mesothelioma Extends Survival

radiotherapy mesothelioma patient

The largest study ever conducted on adjuvant radiotherapy for mesothelioma shows that it can help patients live longer. Pleural mesothelioma is a rare cancer that tends to be highly resistant to standard treatments. Doctors usually have to use a combination of treatments to attack it. These may include chemotherapy, radiotherapy, surgery, and/or immunotherapy. But there are still many questions about what combination of therapies to use and in what order. Adjuvant radiotherapy for mesothelioma is radiation delivered after surgery. Now, radiation oncology researchers in Texas say this approach can extend mesothelioma survival. Killing Mesothelioma Cells with Radiation Mesothelioma cells are hard to kill. Chemotherapy with Alimta (pemetrexed) and cisplatin is the most common treatment. But mesothelioma tumors usually start to … Continue reading Adjuvant Radiotherapy for Mesothelioma Extends Survival »

Induction Therapies Improve Mesothelioma Surgery Outcomes

An induction therapy is the first in a series of therapeutic measures, which, in the case of mesothelioma, may include chemotherapy, radiation, surgery, immunotherapy or other types of experimental treatments.  Because mesothelioma is so treatment-resistant, most patients require a combination of therapies to see results, an approach that clinicians refer to as “multi-modality.” Dr. Laura Donahoe and her colleagues at Toronto Mesothelioma Research Program recently published their summary of novel induction therapies being test for pleural mesothelioma, including a new protocol that they have developed for radiotherapy prior to mesothelioma surgery. The protocol consists of accelerated hemithoracic (one side of the chest) radiation followed by lung-removing extrapleural pneumonectomy (EPP) surgery. “The rationale behind this protocol is to maximize both the … Continue reading Induction Therapies Improve Mesothelioma Surgery Outcomes »

Peritoneal Mesothelioma and Multi-Modality Treatment

Combining surgery, localized chemotherapy and gamma-interferon-1b, and radiation can increase survival for patients with peritoneal mesothelioma, according to a recent study in the American Journal of Clinical Oncology. Currently, no standard treatment exists for peritoneal mesothelioma, a rare cancer of the abdominal lining (peritoneum). Because the disease is typically confined to the abdomen, treatment usually consists of local therapies such as surgery or chemotherapy. In the current study, researchers investigated whether combining surgery with locally delivered chemotherapy, biological therapy (gamma-interferon-1b), and radiation might slow the progression of the disease and improve survival. The study involved 27 patients (average age, 53) with malignant peritoneal mesothelioma. All of the participants underwent surgery in which doctors removed all traces of visible disease—a time-intensive … Continue reading Peritoneal Mesothelioma and Multi-Modality Treatment »